Scott E. Nelson

517 total citations
23 papers, 403 citations indexed

About

Scott E. Nelson is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Scott E. Nelson has authored 23 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Scott E. Nelson's work include Viral-associated cancers and disorders (8 papers), Immune Cell Function and Interaction (4 papers) and Diabetes Management and Research (4 papers). Scott E. Nelson is often cited by papers focused on Viral-associated cancers and disorders (8 papers), Immune Cell Function and Interaction (4 papers) and Diabetes Management and Research (4 papers). Scott E. Nelson collaborates with scholars based in United States and United Kingdom. Scott E. Nelson's co-authors include Assaf Steinschneider, Mark McLean, Deborah L. Segaloff, Mario Ascoli, Shannon C. Kenney, Salman Azhar, Gil B. Gibori, Eric Johannsen, MEREDITH L. WARSHAW and Mrinalini C. Rao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Virology.

In The Last Decade

Scott E. Nelson

21 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott E. Nelson United States 12 124 111 109 92 88 23 403
Jeffrey B. Virgin United States 14 473 3.8× 67 0.6× 99 0.9× 224 2.4× 33 0.4× 23 836
Nicholas Kenny United States 8 150 1.2× 83 0.7× 58 0.5× 102 1.1× 20 0.2× 11 336
Gopalan Shyamala United States 10 176 1.4× 170 1.5× 89 0.8× 172 1.9× 18 0.2× 12 428
Ihab W. Botros United States 9 247 2.0× 202 1.8× 134 1.2× 29 0.3× 36 0.4× 19 549
Rocío Soldati Argentina 12 187 1.5× 183 1.6× 264 2.4× 191 2.1× 19 0.2× 17 614
Nancie J. Solan United States 7 153 1.2× 105 0.9× 250 2.3× 26 0.3× 13 0.1× 7 510
Asomi Sato Japan 11 248 2.0× 80 0.7× 71 0.7× 88 1.0× 7 0.1× 15 511
Sharon L. Eddie United Kingdom 12 179 1.4× 48 0.4× 81 0.7× 84 0.9× 11 0.1× 17 469
Takahide Mori Japan 10 183 1.5× 51 0.5× 140 1.3× 124 1.3× 21 0.2× 16 661
Rajesha Duggavathi Canada 8 138 1.1× 76 0.7× 79 0.7× 184 2.0× 6 0.1× 11 440

Countries citing papers authored by Scott E. Nelson

Since Specialization
Citations

This map shows the geographic impact of Scott E. Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. Nelson more than expected).

Fields of papers citing papers by Scott E. Nelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott E. Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. Nelson. The network helps show where Scott E. Nelson may publish in the future.

Co-authorship network of co-authors of Scott E. Nelson

This figure shows the co-authorship network connecting the top 25 collaborators of Scott E. Nelson. A scholar is included among the top collaborators of Scott E. Nelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott E. Nelson. Scott E. Nelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Deo R., et al.. (2025). IRF6 controls Epstein-Barr virus (EBV) lytic reactivation and differentiation in EBV-infected epithelial cells. PLoS Pathogens. 21(6). e1013236–e1013236.
2.
3.
Bristol, Jillian A., Scott E. Nelson, Makoto Ohashi, et al.. (2024). Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice. PLoS Pathogens. 20(4). e1012132–e1012132. 4 indexed citations
4.
Singh, Deo R., Scott E. Nelson, Jillian A. Bristol, et al.. (2023). Epstein–Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ. Proceedings of the National Academy of Sciences. 120(20). e2219755120–e2219755120. 14 indexed citations
5.
Bristol, Jillian A., Joshua Brand, Makoto Ohashi, et al.. (2022). Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells. PLoS Pathogens. 18(4). e1010453–e1010453. 15 indexed citations
6.
Beauvais, DeannaLee M., et al.. (2022). Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression. Journal of Biological Chemistry. 298(6). 102029–102029. 8 indexed citations
7.
Singh, Deo R., Scott E. Nelson, Jillian A. Bristol, et al.. (2022). Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes. PLoS Pathogens. 18(10). e1010868–e1010868. 5 indexed citations
8.
Ohashi, Makoto, et al.. (2021). Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells. PLoS Pathogens. 17(8). e1009783–e1009783. 19 indexed citations
9.
Romero-Masters, James C., Shane M. Huebner, Makoto Ohashi, et al.. (2020). B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection. PLoS Pathogens. 16(2). e1008365–e1008365. 31 indexed citations
10.
Li, Chunrong, James C. Romero-Masters, Shane M. Huebner, et al.. (2020). EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice. PLoS Pathogens. 16(6). e1008590–e1008590. 21 indexed citations
11.
Nelson, Scott E.. (2011). Management of patients with type 2 diabetes. Current Medical Research and Opinion. 27(10). 1931–1947. 11 indexed citations
12.
Nelson, Scott E.. (2008). The role of insulin analogs in type 2 diabetes in the rural community. Current Medical Research and Opinion. 24(11). 3129–3140. 1 indexed citations
13.
Nelson, Scott E., et al.. (2005). Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair. DNA repair. 5(3). 347–361. 41 indexed citations
14.
Kuritzky, Louis & Scott E. Nelson. (2005). Assessing the controversies of insulin therapy in patients with type 2 diabetes mellitus.. PubMed. 54(6). S3–6. 1 indexed citations
15.
Sugino, Norihiro, R. K. Srivastava, Carlos Telleria, et al.. (1998). Establishment and Characterization of a Simian Virus 40-Transformed Temperature-Sensitive Rat Luteal Cell Line1. Endocrinology. 139(4). 1936–1942. 39 indexed citations
16.
Nelson, Scott E., G. Diane Shelton, Sijin Lei, Jon Lindstrom, & Bianca M. Conti‐Tronconi. (1992). Epitope mapping of monoclonal antibodies to Torpedo acetylcholine receptor γ subunits, which specifically recognize the ϵ subunit of mammalian muscle acetylcholine receptor. Journal of Neuroimmunology. 36(1). 13–27. 16 indexed citations
17.
18.
McLean, Mark, Scott E. Nelson, T. G. Parmer, et al.. (1990). Identification and Characterization of an Abundant Phosphoprotein Specific to the Large Luteal Cell*. Endocrinology. 126(4). 1796–1805. 13 indexed citations
19.
Gibori, Gil B., Iahtasham Khan, MEREDITH L. WARSHAW, et al.. (1988). Placental-Derived Regulators and the Complex Control of Luteal Cell Function. Elsevier eBooks. 44. 377–429. 101 indexed citations
20.
Cleveland, Patrick H., Charles F. McKhann, Kenneth H. Johnson, & Scott E. Nelson. (1974). A microassay for humoral cytotoxicity demonstrating sublethal effects of antibody. International Journal of Cancer. 14(3). 417–426. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey B. Virgin Breakdown of academic impact, for papers by Nicholas Kenny Breakdown of academic impact, for papers by Gopalan Shyamala Breakdown of academic impact, for papers by Ihab W. Botros Breakdown of academic impact, for papers by Rocío Soldati Breakdown of academic impact, for papers by Nancie J. Solan Breakdown of academic impact, for papers by Asomi Sato Breakdown of academic impact, for papers by Sharon L. Eddie Breakdown of academic impact, for papers by Takahide Mori Breakdown of academic impact, for papers by Rajesha Duggavathi
Rankless by CCL
2026